AstraZeneca
AZN
#42
Rank
$305.74 B
Marketcap
$197.22
Share price
1.72%
Change (1 day)
34.77%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2025 (TTM): $5.93

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is $5.93. In 2024 the company made an earnings per share (EPS) of $4.54 an increase over its 2023 EPS that were of $3.84.

EPS history for AstraZeneca from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)$5.9330.62%
2024$4.5418.23%
2023$3.8481.13%
2022$2.12631.03%
2021$0.29-88.11%
2020$2.44136.89%
2019$1.03-39.41%
2018$1.70-28.27%
2017$2.37-14.37%
2016$2.7724.11%
2015$2.23127.55%
2014$0.98-51.96%
2013$2.04-58.95%
2012$4.97-32.2%
2011$7.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
$11.14 87.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
$7.20 21.42%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$1.36-77.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
$3.75-36.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$23.02 288.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
$2.07-65.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
$8.83 48.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$7.31 23.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$3.46-41.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
$3.77-36.46%๐Ÿ‡ฌ๐Ÿ‡ง UK